<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref012">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Zeuzem</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Feinman</surname>
   <given-names>SV</given-names>
  </name>, 
  <name>
   <surname>Rasenack</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Heathcote</surname>
   <given-names>EJ</given-names>
  </name>, 
  <name>
   <surname>Lai</surname>
   <given-names>MY</given-names>
  </name>, 
  <name>
   <surname>Gane</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Peginterferon alfa-2a in patients with chronic hepatitis C</article-title>. 
  <source>The New England journal of medicine</source>. 
  <year>2000</year>;
  <volume>343</volume>(
  <issue>23</issue>):
  <fpage>1666</fpage>â€“
  <lpage>72</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJM200012073432301</pub-id> .
  <?supplied-pmid 11106715?>
  <pub-id pub-id-type="pmid">11106715</pub-id>
 </mixed-citation>
</ref>
